The association of proton pump inhibitors and hypomagnesemia in the community setting

Out-of-Hospital Use of Proton Pump Inhibitors and Hypomagnesemia at Hospital Admission: A Nested Case-Control Study

(2013) Ioannis Koulouridis et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Electrolyte Disorders in Community Subjects: Prevalence and Risk Factors

(2013) George Liamis et al.   AMERICAN JOURNAL OF MEDICINE

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Recurrent Hypomagnesemia With Proton-Pump Inhibitor Rechallenge

(2013) Maria Quasdorff et al.   ANNALS OF INTERNAL MEDICINE

Proton-pump inhibitor use is associated with low serum magnesium concentrations

(2013) John Danziger et al.   KIDNEY INTERNATIONAL

Serum magnesium and proton-pump inhibitors use: a cross-sectional study

(2013) Gustavo Adolpho Moreira Faulhaber et al.   Revista da Associacao Medica Brasileira

Systematic review: hypomagnesaemia induced by proton pump inhibition

(2012) M. W. Hess et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Continuation of Statin Therapy and Primary Prevention of Nonfatal Cardiovascular Events

(2012) Varda Shalev et al.   AMERICAN JOURNAL OF CARDIOLOGY

Evaluation of Hypomagnesemia: Lessons From Disorders of Tubular Transport

(2012) Henrik Dimke et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Low Serum Magnesium and the Development of Atrial Fibrillation in the Community

(2012) Abigail May Khan et al.   CIRCULATION

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2012) Takao Tamura et al.   International Journal of Medical Sciences

Uses of proton pump inhibitors and hypomagnesemia

(2012) Jen-Tzer Gau et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Hypomagnesemia and Proton Pump Inhibitors

(2011) Tania Weber Furlanetto   ARCHIVES OF INTERNAL MEDICINE

Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins

(2011) Daniel Kurnik et al.   CLINICAL ENDOCRINOLOGY

Adverse Effects of Long-Term Proton Pump Inhibitor Therapy

(2011) Edward Sheen et al.   DIGESTIVE DISEASES AND SCIENCES

Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease

(2010) Abigail May Khan et al.   AMERICAN HEART JOURNAL

A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia

(2010) Ewout J. Hoorn et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors

(2010) Thorsten Reffelmann et al.   ATHEROSCLEROSIS

Proton pump inhibitors and severe hypomagnesaemia

(2010) Tim Cundy et al.   CURRENT OPINION IN GASTROENTEROLOGY

The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel

(2010) Gabriel Chodick et al.   HEALTH POLICY

Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series

(2010) J. D. Mackay et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Genome-Wide Association Studies of Serum Magnesium, Potassium, and Sodium Concentrations Identify Six Loci Influencing Serum Magnesium Levels

(2010) Tamra E. Meyer et al.   PLoS Genetics

Severe hypomagnesaemia in long-term users of proton-pump inhibitors

(2008) T. Cundy et al.   CLINICAL ENDOCRINOLOGY